Enhanced Investments - Financial Portal

Replays Available from the Influential Companies of the 2022 Sequire Cannabis and Psychedelic Conference

Published: 2022-04-26 13:00:00 ET

LOS ANGELES, April 26, 2022 (GLOBE NEWSWIRE) -- SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, hosted the 2022 Cannabis and Psychedelic Conference, a preeminent virtual investor event, on April 20th.

This elite event featured presentations from over 25 premier cannabis and psychedelic stock market companies, as well as talks with industry experts. Marijuana Company Of America Inc, Item 9 Labs, Delic Corp, Can B Corp., and Pressure BioSciences, Inc. were the sponsors of this exciting event.

Visit the event website to see all the presentations and keynotes: https://cannabis-conference22.mysequire.com/

Keynotes and panels:

Exploring the Value and Application of Botanical and moSynthetic Formulations in Psychedelic Medicine– In this conversation, Dr. Matt Johnson, Joel Stanley, and David Drapkin discuss clinical research on psychedelic compounds, specifically differentiating the development, usage, and value of botanical formulations and synthetic or single molecule formulations.
Building An Industry Worthy of The Plant – During this conversation Steve DeAngelo and Andrew DeAngelo share insider knowledge about the current cannabis landscape, latest developments in the industry, and what to expect in the near future as cannabis legalization expands across the nation.
Boom & Bust Cycles of the Cannabis Industry – Glenn Mattson discusses the cycles of the Cannabis industry. Mr. Mattson has over 20 years of institutional equity analyst experience. Most recently as Senior Equity Analyst for Ladenburg Thalmann Mr. Mattson has spearheaded the effort to establish a cannabis research platform.
Debt Capital For Everyone with James Dworkin – Hear from James DWorkin, Managing Director of Searsport Global Securities', on the state of the cannabis debt, equity, and M&A markets and how everyone can access them.

Most viewed presentations:

See all replays from all of these cannabis and psychedelic focused companies for free:

Visit the event website to see all the presentations and keynotes: https://cannabis-conference22.mysequire.com/

About SRAXSRAX (NASDAQ: SRAX) is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX, visit srax.com and mysequire.com .

Cautionary Statement Regarding Forward-Looking Information:This news release contains "forward-looking statements'' made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to future, not past, events and may often be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "seek" or "will." Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Specific risks and uncertainties that could cause our actual results to differ materially from those expressed in our forward-looking statements include risks inherent in our business, and our need for future capital. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in SRAX's periodic reports filed with the Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the year ended December 31, 2020, its Quarterly Reports on Form 10-Q as well as and in other reports filed with the SEC. We do not assume any obligation to update any forward-looking statements.

ContactsBri Kelvininvestors@srax.com

Source: SRAX

Enhanced Investments, Inc.
329 South Oyster Bay Road #2085
Plainview, NY 11803
team@eninvs.com

Important disclosures

Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.

Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy or sell securities.
Past performance is no guarantee of future results. Any historical returns, expected returns [or probability projections] are hypothetical in nature and may not reflect actual future performance.
All the strategies assume investments in equity invstrumenta only and are more relevant for "agressive investment profile". Eastern European flagship strategy assumes using up to 20% leverage of total portfolio. GlobalCommodities and US Growth strategy currently assume no leverage.
Results for the Enhanced Investments strategies as compared to the performance of Illustrative Benchmarks is for informational purposes only. Our investment program does not mirror that of the Illustrative Benchmarks and the volatility may be materially different from the volatility of Illustrative Benchmarks. Reference or comparison to an Illustrative Benchmark does not imply that strategies of Enhanced Investments will be constructed in the same way as the Illustrative Benchmark or achieve returns, volatility, or other results similar to those of the Illustrative Benchmark. The S&P 500 is an unmanaged market capitalization-weighted index of 500 common stocks chosen for market size, liquidity, and industry group representation to represent U.S. equity performance.
Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.